VectorY and Shape Therapeutics Partner to Develop AAV5-Based Vectorized Antibodies for Neurodegenerative Diseases Read more
Wheeler Bio and MindImmune Therapeutics Partner to Support Alzheimer’s Prevention Program MITI-101 Read more
Adagene and Exelixis Expand SAFEbody Collaboration to Develop Third Masked Antibody-Drug Conjugate Read more
FDA Grants Breakthrough Therapy Designation to Raludotatug Deruxtecan for CDH6-Positive Platinum-Resistant Ovarian and Related Cancers Read more